Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.

Okunuki Y, Usui Y, Nagai N, Kezuka T, Ishida S, Takeuchi M, Goto H. Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan. Invest Ophthalmol Vis Sci. 2009 May; 50(5):2255-61.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.